Talvey (talquetamab) - J&J
Tecvayli (teclistamab) - Genmab, J&J
Tecvayli + Talvey: Initiation of MonumenTAL-6 trial for 2 & 3L r/r multiple myeloma in 2024 (J&J) - Dec 16, 2023 - J&J 2023 Enterprise Business Review 
New trial • Hematological Malignancies • Multiple Myeloma • Oncology
https://jnjbusinessreview.q4ir.com/files/doc_downloads/2023/Innovative-Medicine-Presentation.pdf
 
Dec 16, 2023
 
 
94345666-70ba-4617-a605-31088dcc1da9.png